Moreover, duodenal mucosal AMPK was activated through the intraduodenal infusion of metformin and contributed to glucose-lowering effects in a model of obesity and diabetes (Duca et al., 2015). The gene discussed is PRKAA1; the disease is obesity due to melanocortin 4 receptor deficiency.